No additional protections are needed beyond standard research consent procedures

Involuntarily committed patients are a vulnerable population requiring enhanced consent procedures, independent monitors or patient advocates, and heightened IRB scrutiny to ensure protection of their rights and welfare

Involuntarily committed patients cannot participate in research under any circumstances

Additional protections are only required for pharmaceutical industry-sponsored studies